From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q4 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司最近从“需要说服买家考虑”转变为“已获批准、指定、列入、合格、注册、报销或预先授权”的买家采购、报销、配方、规格、采购、网络、目录或计划系统中的选择,从而使得公司未来业务的重要部分可以在没有每次订单的单独销售事件的情况下到达,并且管理层传达这种准入状态是新的,以至于它解锁的大部分量仍在前方,尚未反映在报告结果中。 在记录中,管理层提到了与Desktop Metal的战略合作,将iTero Element Flex扫描仪作为Desktop Labs的首选修复扫描仪,并连接牙医与Desktop Labs的服务。这似乎是一种将公司产品纳入特定实验室网络的指定或首选地位。但这是否意味着公司已进入买方的常规采购路径,且无需每次单独销售?管理层说:“我们的合作反映了我们对关系的承诺,我们预计这种关系将发展和扩展,以将先进的修复工作流程推向市场。”这暗示了未来的扩展,但当前状态是否已导致大量业务自动流入?管理层没有明确说这种准入是新的,且大部分量尚未实现。此外,管理层还提到了扫描仪租赁计划、认证二手设备等,但这些是销售模式,不是准入状态。 关于“数字订阅计划”(DSP),管理层说:“我们对我们基于订阅的计划如DSP感到满意,该计划在连续和同比基础上增长,并预计将继续在其他地区扩展DSP。”这似乎是一种订阅模式,但并未明确说明这是否是新的准入状态,且大部分量尚未实现。 管理层还提到了“Invisalign训练医生”的数量,但这是培训,不是准入。 因此,没有明确证据表明管理层描述了公司最近从候选者转变为默认选择,且这种转变是新的,大部分量尚未实现。记录中提到的合作和计划更像是常规的销售关系或分销协议,而不是将公司插入到买方的系统路径中。 因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.